{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:08:13Z","timestamp":1792213693063,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.anai.2019.08.463","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T02:02:11Z","timestamp":1567735331000},"page":"573-581.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Oral immunotherapy for multiple foods in a pediatric allergy clinic setting"],"prefix":"10.1016","volume":"123","author":[{"given":"Amy A.","family":"Eapen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Lavery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaweriah S.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle B.","family":"Lierl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2019.08.463_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.iac.2011.11.008","article-title":"The epidemiology of IgE-mediated food allergy and anaphylaxis","volume":"32","author":"Allen","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2019.08.463_bib2","first-page":"1","article-title":"Trends in allergic conditions among children: United States, 1997-2011","volume":"121","author":"Jackson","year":"2013","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.anai.2019.08.463_bib3","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0091-6749(03)02026-8","article-title":"Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study","volume":"112","author":"Sicherer","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2019.08.463_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/mai.2001.115755","article-title":"A\u00a0voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants","volume":"108","author":"Sicherer","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1573396314666180507115115","article-title":"Anaphylaxis in children: epidemiology, risk factors and management","volume":"14","author":"Anagnostou","year":"2018","journal-title":"Curr Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2019.08.463_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12016-018-8708-x","article-title":"Beyond avoidance: the psychosocial impact of food allergies","volume":"57","author":"Feng","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/pai.12905","article-title":"The impact of oral food challenges for food allergy on quality of life: a systematic review","volume":"29","author":"Kansen","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib8","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2011-0204","article-title":"The prevalence, severity, and distribution of childhood food allergy in the United States","volume":"128","author":"Gupta","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2019.08.463_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JAA.S141636","article-title":"Current perspectives on tree nut allergy: a review","volume":"11","author":"Weinberger","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.anai.2019.08.463_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A\u00a0randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2019.08.463_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-term outcome of peanut oral immunotherapy: real life experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2018.06.016","article-title":"Quality of life of food-allergic patients before, during, and after oral immunotherapy","volume":"7","author":"Epstein-Rigbi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.08.463_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-10-1","article-title":"Safety and feasibility of oral immunotherapy to multiple allergens for food allergy","volume":"10","author":"B\u00e9gin","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2019.08.463_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1710-1492-10-7","article-title":"Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab","volume":"10","author":"B\u00e9gin","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2019.08.463_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00005-016-0420-z","article-title":"The use of omalizumab in food oral immunotherapy","volume":"65","author":"Labrosse","year":"2017","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.anai.2019.08.463_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13223-017-0223-8","article-title":"Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab","volume":"13","author":"Andorf","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2019.08.463_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2468-1253(17)30392-8","article-title":"Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial","volume":"3","author":"Andorf","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2019.08.463_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13223-017-0224-7","article-title":"Feasibility of sustained response through long-term dosing in food allergy immunotherapy","volume":"13","author":"Andorf","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2019.08.463_bib21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jaci.2009.09.042","article-title":"Adverse reactions during peanut oral immunotherapy home dosing","volume":"124","author":"Varshney","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2016.07.030","article-title":"Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy","volume":"139","author":"Virkud","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2019.08.463_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaip.2016.11.010","article-title":"Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab","volume":"5","author":"Burk","year":"2017","journal-title":"Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2019.08.463_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/pai.12554","article-title":"Oral immunotherapy for peanut allergy induces eosinophilic esophagitis: three pediatric case reports","volume":"27","author":"Semancik","year":"2016","journal-title":"Pediatric Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2019.08.463_bib25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9925","key":"10.1016\/j.anai.2019.08.463_bib26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2019.08.463_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/pai.12355","article-title":"Impact of oral immunotherapy on quality of life in egg-allergic children","volume":"26","author":"Vasquez-Ortiz","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2019.08.463_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/cea.13256","article-title":"High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children","volume":"49","author":"Kulis","year":"2019","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2019.08.463_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12016-018-8678-z","article-title":"The use of biomarkers to predict aero-allergen and food immunotherapy responses","volume":"55","author":"Sindher","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.anai.2019.08.463_bib30","series-title":"National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma","year":"2007"},{"issue":"6","key":"10.1016\/j.anai.2019.08.463_bib31","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2012.10.017","article-title":"Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report","volume":"130","author":"Sampson","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112061931052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112061931052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:23:16Z","timestamp":1761052996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112061931052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S108112061931052X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2019.08.463","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral immunotherapy for multiple foods in a pediatric allergy clinic setting","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2019.08.463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}